11th week of 2011 patent applcation highlights part 36 |
Patent application number | Title | Published |
20110064775 | METALLO-ORGANIC SYSTEM FOR THE ENCAPSULATION AND RELEASE OF COMPOUNDS OF INTEREST, METHOD FOR OBTAINING SAME AND USES THEREOF - The present invention discloses a metallo-organic system that includes: a metal ion salt or complex; at least one organic ligand; and a substance of interest to be encapsulated, belonging to the group comprising a biological entity, a drug, a vaccine, a diagnostic contrast agent, a marker, an organic compound, an inorganic compound, a metallo-organic compound or a nanomaterial or nanodevices. Also disclose is the process for obtaining same and the uses thereof for the release and/or protection and/or storage of said substances in the pharmaceutical, chemical, environmental, medical and industrial sectors. | 2011-03-17 |
20110064776 | DENTAL COMPOSITION CONTAINING ORGANIC NANOTUBE - Disclosed is a dental composition, comprising unsaturated double bond-containing monomers and/or oligomers, a catalytic amount of polymerization initiator to initiate polymerization, and a filler, wherein the dental composition comprises an organic nanotube containing an antibacterial or anticariogenic material to inhibit or prevent tooth decay. | 2011-03-17 |
20110064777 | LIVE LACTOBACILLUS SOAP AND METHOD FOR DELIVERING LACTOBACILLUS TO SKIN TISSUE - Microbiotic Soap made with the addition of | 2011-03-17 |
20110064778 | CONTINUOUS MULTI-MICROENCAPSULATION PROCESS FOR IMPROVING THE STABILITY AND STORAGE LIFE OF BIOLOGICALLY ACTIVE INGREDIENTS - The invention relates to microcapsules, and a continuous micro-encapsulation water-in-oil-in-water microencapsulation process through in situ and interfacial polymerization of the emulsion. The formulation comprises a continuous water phase having a dispersion of microcapsules which contain oil drops and wherein the inside of each oil phase drop—containing optionally oil-soluble materials—there is a dispersion of water, or aqueous extract or water dispersible material or water soluble material. The oil drops are encapsulated with a polymerisable material of natural origin. Such microcapsules are appropriated for spray-dry processes, to be used as dry powder, lyophilised, self-emulsifiable powder, gel, cream and any liquid form. The active compounds included in the microcapsules are beneficial to the health and other biological purposes. Such formulations are appropriate to be incorporated in any class of food, especially for the production of nutraceuticals, as well as cosmetic products (such as rejuvenescence creams, anti-wrinkle creams, gels, bath and shower consumable products and sprays). The preparations are adequate to stabilise compounds added to the food, media for cultivating microbes and nutraceuticals, especially those which are easily degradable or oxidizable. | 2011-03-17 |
20110064779 | PEARLESCENT PIGMENTS BASED ON FINE AND THIN SUBSTRATES - Pearlescent pigments including a largely transparent platelet-shaped substrate having a density ρ | 2011-03-17 |
20110064780 | POLYMERIC PHEROMONE FORMULATION AND METHOD OF USE TO CALM STRESS-RELATED BEHAVIOR IN MAMMALS OVER AN EXTENDED PERIOD OF TIME - The present invention is directed to a polymeric formulation for controlling animal behavior comprising a low melting point polymer or copolymer, an unsaturated long chain fatty alcohol, and an animal-appeasing pheromone to produce a solid slow release generator of the pheromone. The system is useful for making animal collars and the like. | 2011-03-17 |
20110064781 | NOVEL HEPARIN ENTITIES AND METHODS OF USE - The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive. | 2011-03-17 |
20110064782 | METHODS AND COMPOSITIONS FOR TISSUE REGENERATION - A decellularised collagen-containing matrix for guided tissue regeneration, wherein the matrix is derived from a natural tissue material and is substantially free of non-fibrous tissue proteins, cellular elements and lipids or lipid residues and wherein the matrix displays the original collagen fibre architecture and molecular ultrastructure of the natural tissue material from which it is derived. The decellularised collagen-containing matrix is useful as an implant for guided tissue regeneration, having a capacity to induce guided regeneration of host tissue. | 2011-03-17 |
20110064783 | Flavor Impregnation Of A Chewing Gum Core - A method of adding flavor to a chewing gum core of a chewing gum, the chewing gum including active pharmaceutical ingredients, the method of adding flavor to a chewing gum core including the steps of: providing a chewing gum core including gum base, impregnating the chewing gum core by adding at least one dose of liquid flavor mixture onto the chewing gum core prior to any optional coating of the chewing gum core, wherein at least the flavor in the liquid flavor mixture has affinity for the gum base in the chewing gum core. | 2011-03-17 |
20110064784 | METHOD FOR PRODUCING A THREE-DIMENSIONAL MACROPOROUS FILAMENT CONSTRUCT BASED ON PHASE INVERSION AND CONSTRUCT THEREBY OBTAINED - The present invention relates to a method for producing a three-dimensional macroporous filament construct comprising interconnected microporous filaments showing a suitable surface roughness and microporosity. The method comprises the steps of: a) preparing a suspension comprising particles of a predetermined material, a liquid solvent, one or more binders and optionally one or more dispersants, b) depositing said suspension in the form of filaments in a predetermined three-dimensional pattern, preferably in a non-solvent environment, thereby creating a three-dimensional filament-based porous structure, c) inducing phase inversion, whereby said filaments are transformed from a liquid to a solid state, by exposing said filaments during the deposition of the filaments with a non-solvent vapour and to a liquid non-solvent, d) thermally treating the structure of step d) by calcining and sintering said structure. The invention further provides a three-dimensional macroporous filament construct comprising interconnected microporous filaments showing a specific surface roughness and microporosity. The invention also relates to various uses of the construct, including its use for the manufacture of a biomedical product, such as a synthetic bone implant or bone graft. | 2011-03-17 |
20110064785 | Nanostructure-Enhanced Platelet Binding and Hemostatic Structures - Methods, systems, and apparatuses for nanomaterial-enhanced platelet binding and hemostatic medical devices are provided. Hemostatic materials and structures are provided that induce platelet binding, including platelet binding and the coagulation of blood at a wound/opening caused by trauma, a surgical procedure, ulceration, or other cause. Example embodiments include platelet binding devices, hemostatic bandages, hemostatic plugs, and hemostatic formulations. The hemostatic materials and structures may incorporate nanostructures and/or further hemostatic elements such as polymers, silicon nanofibers, silicon dioxide nanofibers, and/or glass beads into a highly absorbent, gelling scaffold. The hemostatic materials and structures may be resorbable. | 2011-03-17 |
20110064786 | NOVEL USE OF BASIC FIBROBLAST GROWTH FACTOR IN THE DE-DIFFERENTIATION OF ANIMAL CONNECTIVE TISSUE CELLS - De-differentiation protocols are described herein for generating progenitor cells from adult connective tissue, in particular adult human fibroblasts. The de-differentiation protocols described herein comprise culturing the differentiated cells with an amount of FGF2 to de-differentiate the cells. These de-differentiated cells may then be cultured and used for experimentation, amplification and clinical applications. The clinical applications include the use of the cells for tissue and cell based therapies. | 2011-03-17 |
20110064787 | Detoxifying patch - A detoxifying patch is disclosed that is preferably applied to the soles of the feet as a therapeutic treatment to remove toxins from the body and increase blood circulation. The patch includes a pouch and a backing with an optional foil backing. The pouch contains various ingredients including mandarin wood vinegar, mandarin oil, bamboo vinegar, tourmaline, magnets, magnetic powder and/or zeolite. The patch is secured to a user by an adhesive on the backing or optionally a separate adhesive strip. | 2011-03-17 |
20110064788 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF ADDICTION - The invention provides transdermal patches comprising an adhesive and a composition comprising naltrexone and either methyl oleate or isopropyl myristate, a kit comprising a plurality of such transdermal patches, a composition comprising naltrexone and methyl oleate, such a composition for use as a medicament, and compositions comprising naltrexone and methyl oleate or isopropyl myristate for use in the treatment of alcoholism or opiate addiction. | 2011-03-17 |
20110064789 | DOCOSAHEXANOIC ACID AS INHIBITOR OF H. PYLORI - The present invention concerns a method for preventing, modulating or curing in a mammal, the infections with | 2011-03-17 |
20110064790 | ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES - Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses and virus-like vehicles to act as a transport mechanism to deliver ribosomal RNA molecules to target cells in the body. Delivering to the Beta cells in the body the ribosomal RNA needed to assist ribosomes with the construction of insulin or insulin receptors will lead to enhanced production of biologically active insulin or insulin receptors by Beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors, the result of which will help properly regulate blood glucose levels throughout the body utilizing innate cellular regulatory mechanisms. | 2011-03-17 |
20110064791 | Self forming, thermodynamically stable liposomes and their applications - Certain diacylglycerol-polyethyleneglycol (DAG-PEG) lipids are especially useful for forming thermodynamically stable liposomes. Such liposomes are useful for a variety of purposes, including the delivery of therapeutic agents. | 2011-03-17 |
20110064792 | Method for Opening Tight Junctions - The present invention is directed to a method and use of RNA interference (RNAi) for the transient, reversible and controlled opening of the tight junctions of the blood brain barrier and/or the blood retinal barrier. This method may be used in the treatment of many diseases and disorders which require the opening of the blood brain barrier and/or blood retinal barrier. Such methods generally involve the use of an RNAi-inducing agent, such as siRNA, miRNA, shRNA or an RNAi-inducing vector whose presence within a cell results in production of an siRNA or shRNA, targeting tight junction proteins to open the blood brain barrier and/or blood retinal barrier. | 2011-03-17 |
20110064793 | INHIBITORS OF HIV REPLICATION AND METHOD OF TREATMENT OF HIV INFECTIONS - The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections. | 2011-03-17 |
20110064794 | Drug Delivery System, its Preparation Process and Use - A protein-phospholipid dispersion preparation in a drug delivery system is provided, in which the weight ratio of protein to phospholipid is 1:300-300:1 and the particle size is between 5 nm and 1000 nm. The preparation process of the said preparation contains the mixture of protein phase and phospholipid phase and the homogenization process. The said drug delivery system can be used in many different pharmaceutical agents. | 2011-03-17 |
20110064795 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers - The invention relates to an immunogenic composition which comprises, firstly, a carrier and, secondly, as antigenic structure, conjugates comprising all or part of the amino acid sequences of at least one peptide derived from an extracellular loop of the P-170 protein, each peptide being combined with several molecules of fatty acid containing a carbon chain of between C12 and C24 so as to allow, under suitable administration conditions, the induction of anti-P-170 antibodies. | 2011-03-17 |
20110064796 | CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION - A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions. | 2011-03-17 |
20110064797 | CAPSULE OF THERMOGENIC CELLS FOR TREATING A METABOLIC DISEASE - Described herein are methods and devices for treating a metabolic disease that involve implanting a micro-device into a tissue of a subject having a metabolic disease. The micro-device includes a plurality of thermogenic cells encapsulated in a biocompatible capsule. The capsule includes a core to accommodate the plurality of thermogenic cells and a porous immunoprotective membrane that allows for metabolic interaction between the plurality of thermogenic cells and the tissue. | 2011-03-17 |
20110064798 | SUSPENSION CONTAINING HYDRONIUM STABILIZED COLLOIDAL SILICIC ACID NANOPARTICLES, FORMULATION OBTAINED FROM THE SAID DILUTESUSPENSION, POWDER OBTAINED FROM THE SAID DE-HYDRATED SUSPENSION, COMPOSITIONS OBTAINED FROM THE SAID POWDER, PREPARATION AND USE - The present invention relates to hydronium stabilized silicic acid nanoparticles, to the formulation obtained from the said diluted suspension, to the powder obtained from the said dehydrated suspension and to the preparation or dosage form obtained from the said suspension, formulation or powder, to their preparation and their use in all kinds of applications in the domains of food, medicine, pharmaceutics, cosmetics. The present invention provides a stable suspension of colloidal silicic acid nanoparticles having a pH lower than 0.9, a molar silicon concentration between 0.035 and 0.65, a free water concentration of at least 30% (w/v) and a ratio between hydronium ion and Si molar concentrations higher than 2 and preferably inferior to 4. The present invention further provides a method for preparing a stable suspension of colloidal silicic acid nanoparticles, which comprises the steps of providing an aqueous inorganic or organic silicon solution and quick mixing said aqueous inorganic or organic silicon solution with water containing a strong acidic compound at a temperature inferior at 30° C., preferably comprised between 1 and 25° C., to form a suspension of colloidal silicic acid nanoparticles having a pH lower than 0.9, stabilized by hydronium ions, the ratio between hydronium ions and Si molar concentrations being higher than 2 and preferably inferior to 4, for a molar silicon concentration between 0.035 and 0.65 and a free water concentration of at least 30% (w/v). | 2011-03-17 |
20110064799 | Pancreatic Enzyme Compositions and Methods for Treating Pancreatitis and Pancreatic Insufficiency - Compositions of the present invention, comprising the combination of enterically coated and uncoated pancreatic enzyme-containing beads are useful for treating or preventing pancreatitis pain, and optionally disorders associated with digestive enzyme deficiencies. | 2011-03-17 |
20110064800 | NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCLOSPORINE - The present invention is directed to a composition comprising a nanoparticulate cyclosporine having improved bioavailability. The nanoparticulate cyclosporine particles of the composition have an effective average particle size of less than about 2000 nm in diameter and are useful in the prevention and treatment of organ transplant rejection and autoimmune diseases such as psoriasis, rheumatoid arthritis, and other related diseases. The invention also relates to a controlled release composition comprising a cyclosporine or a nanoparticulate cyclosporine that in operation delivers the drug in a pulsed or bimodal manner for the prevention and treatment of organ transplant rejection and autoimmune diseases such as psoriasis, rheumatoid arthritis, and other related diseases. | 2011-03-17 |
20110064801 | Pharmaceutical Formulations Containing an SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 2011-03-17 |
20110064802 | IMPROVED CAPSULE WITH AIR-VENTS - The invention relates to a capsule comprising a hollow tubular body ( | 2011-03-17 |
20110064803 | NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2 - The present invention is directed to compositions comprising a nanoparticulate vitamin K2 having improved bioavailability. The nanoparticulate vitamin K2 particles of the composition have an effective average particle size of less than about 2000 nm and are useful in the prevention and treatment of osteoporosis. The invention also relates to a controlled release composition comprising a vitamin K2 or a nanoparticulate vitamin K2 that in operation delivers the drug in a pulsed or multi-modal manner for the prevention and treatment of osteoporosis. | 2011-03-17 |
20110064804 | Methods and Compositions for the Treatment of CNS-Related Conditions - The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease. | 2011-03-17 |
20110064805 | Porous cellulose aggregate and molding composition thereof - A porous cellulose aggregate characterized by having a secondary aggregate structure resulting from aggregation of primary cellulose particles, having a pore volume within a particle of 0.265 to 2.625 cm | 2011-03-17 |
20110064806 | SOLID COMPOSITIONS COMPRISING AN OXADIAZOANTHRACENE COMPOUND AND METHODS OF MAKING AND USING THE SAME - The invention provides solid compositions comprising (S)-3-(4′-Cyano-biphenyl-4-yl)-2-{[(3S,7S)-3-[4-(3,4-dichloro-benzyloxy)-phenyl]-1-methyl-2-oxo-6-((S)-1-phenyl-propyl)-2,3,5,6,7,8-hexahydro-1H-4-oxa-1,6-diaza-anthracene-7-carbonyl]-amino}-propionic acid (OC-1) or a salt thereof and methods of making and using those compositions. The invention also provides the monohydrochloride salt of (S)-3-(4′-Cyano-biphenyl-4-yl)-2-{[(3S,7S)-3-[4-(3,4-dichloro-benzyloxy)-phenyl]-1-methyl-2-oxo-6-((S)-1-phenyl-propyl)-2,3,5,6,7,8-hexahydro-1H-4-oxa-1,6-diaza-anthracene-7-carbonyl]-amino}-propionic acid. | 2011-03-17 |
20110064807 | EXTENDED RELEASE FORMULATION OF LEVETIRACETAM - An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system. | 2011-03-17 |
20110064808 | EXTENDED RELEASE FORMULATION OF LEVETIRACETAM - The present invention relates to extended release pharmaceutical compositions of Levetiracetam and processes for preparing the same. The extended release tablet of Levetiracetam is with a core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patient's blood plasma. The composition also exhibits no food effect. | 2011-03-17 |
20110064809 | SCAFFOLDS - The invention relates to methods of preparing tissue implants for use in the augmentation, repair and regeneration of tissues. | 2011-03-17 |
20110064810 | TISSUE ENGINEERING METHOD FOR ORGAN RECONSTRUCTION USING INJECTABLE MATRIX - The various embodiments herein relate to an injectable matrix used for regeneration, reconstruction, repair or replacement of organ or tissue. The injectable matrix consists of a synthetic and natural polymer, a stem cell niche and nanoparticles in the form of cups filled with growth factor and physiologic agent. The embodiments herein also provide a method for regeneration, reconstruction, repair or replacement of organ or tissue. In the method, an injectable matrix is injected to create three dimensional matrix system or network in an area of the desired tissue or organ, migration of blood circulatory stem cells or tissue-specific progenitor cells occur to the injected area of the tissue or organ. The growth factors and physiological agent present in the nanocups are released. The stem cells proliferate and differentiate to form the desired organ or tissue. | 2011-03-17 |
20110064811 | Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide - The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith. | 2011-03-17 |
20110064812 | Oral Solid Dosage Form Containing Nanoparticles and Process of Formulating the Same Using Fish Gelatin - An oral solid dosage form containing nanoparticles is made by (a) reducing the particle size of at least one pharmaceutically active ingredient dispersed in a solution containing fish gelatin to form a nanosuspension and (b) freeze-drying the nanosuspension of step (a) to form the oral solid dosage form. | 2011-03-17 |
20110064813 | USE OF SALSALATE WITH OR WITHOUT CAFFEINE AND WITH OR WITHOUT OMEGA 3, AND OTHER PHARMACEUTICAL COMPOUNDS IN A DISTINCTIVELY UNIQUE NANO-PARTICULATE CAPSULE AND TABLET - The invention relates to a compound and administration of the compound to mammals containing salsalate in a nanofied form to reduce inflammation. This compound and administration may be combined with caffeine, omega 3 fatty acids, sodium bicarbonate, and/or simvastatin to further benefit that administration. | 2011-03-17 |
20110064814 | STABLE PHARMACEUTICAL PRODUCTS - Provided herein is a stable pharmaceutical product comprising a dry powder inhalation device, and a pharmaceutical composition that comprises R,R-Formoterol L-tartrate salt, in particular crystalline R,R-formoterol L-tartrate; and ciclesonide. | 2011-03-17 |
20110064815 | SILICIA FOR THE INHINITION OF A PROTEASE - There is provided a silica for use to inhibit a protease. In particular there is provided a silica for treatment or prevention of a disease or condition associated with adverse protease activity or adverse proteolytic degradation within the gastrointestinal tract. | 2011-03-17 |
20110064816 | ATORVASTATIN COMPOSITIONS - Compositions containing atorvastatin, including its pharmaceutically acceptable salts, solvates, hydrates, enantiomers, polymorphs and their mixtures, and processes for preparing the same. Further aspects relate to pharmaceutical formulations comprising compositions containing atorvastatin, or a salt thereof, processes for preparing the same, and their methods of use, treatment and administration. | 2011-03-17 |
20110064817 | CONTINUOUS MULTI-MICROENCAPSULATION PROCESS FOR IMPROVING THE STABILITY AND STORAGE LIFE OF BIOLOGICALLY ACTIVE INGREDIENTS - The invention relates to microcapsules, and a continuous micro-encapsulation water-in-oil-in-water microencapsulation process through in situ and interfacial polymerization of the emulsion. The formulation comprises a continuous water phase having a dispersion of microcapsules which contain oil drops and wherein the inside of each oil phase drop—containing optionally oil-soluble materials—there is a dispersion of water, or aqueous extract or water dispersible material or water soluble material. The oil drops are encapsulated with a polymerisable material of natural origin. Such microcapsules are appropriated for spray-dry processes, to be used as dry powder, lyophilised, self-emulsifiable powder, gel, cream and any liquid form. The active compounds included in the microcapsules are beneficial to the health and other biological purposes. Such formulations are appropriate to be incorporated in any class of food, especially for the production of nutraceuticals, as well as cosmetic products (such as rejuvenescence creams, anti-wrinkle creams, gels, bath and shower consumable products and sprays). The preparations are adequate to stabilise compounds added to the food, media for cultivating microbes and nutraceuticals, especially those which are easily degradable or oxidizable. | 2011-03-17 |
20110064818 | PHARMACEUTICAL COMPOSITION AND A METHOD FOR THE PRODUCTION THEREOF - The invention relates to producing medicinal agents for treating diabetes. There is proposed a method for producing a pharmaceutical composition containing insulin on a polysaccharide carrier, which involves mixing initial ingredients, wherein there is provided, for mixing, supplying positively charged chitosan sol with pH of 3.5 to 4.5 and negatively charged zinc free insulin, which is taken in the form of a colloidal solution or in the form of nanosized crystalline particles, bringing the pH of the mixed sol to a value of 5.5 to 6.5, producing a gel and dehydrating the produced gel to obtain solid particles, the size of which ranges from 10 to 100 mkm. The method makes it possible to produce a stable controlled release insulin-containing composition for peroral administration | 2011-03-17 |
20110064819 | ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS - The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles using Hip agents. Also provided are compositions comprising particulate carriers obtainable by such methods and uses of such compositions in treatment. | 2011-03-17 |
20110064820 | Pharmaceutical Compositions Comprising Phosphate-Binding Polymer - The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Disclosed are compositions comprising wet granulated Sevelamer carbonate free of added metal ions and/or added monovalent anion source. | 2011-03-17 |
20110064821 | ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS - The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles. Also provided are methods of delivery of proteins across the blood brain barrier in nanoparticles, and uses of such compositions in treatment. | 2011-03-17 |
20110064822 | BIOMATERIAL AND PREPARATION METHOD THEREOF - A biomaterial prepared from a process comprising dehydrating the fish scales until the fish scales containing less than about 50% of water, and grinding the dehydrated fish scales into ground particles each having an average size of less than about 10,000 μm in diameter, wherein the ground particles contain a mixture of sponge like matrix and powder is provided. The invention also provides a biomaterial prepared from fish scales by a process comprising subjecting the fish scales to a heat treatment at a temperature of less than about 200° C. | 2011-03-17 |
20110064823 | TRANSDERMAL DELIVERY APPARATUS AND METHOD - An apparatus and method for applying a beneficial agent to the skin is disclosed in one embodiment of the invention as including first and second chemical reactants, each being compatible with the skin. The first and second chemical reactants react with one another to generate a beneficial agent and enhance the permeability of the skin (e.g., by generating heat). The beneficial agent may then be applied to the skin while the permeability of the skin is enhanced. In selected embodiments, the first chemical reactant includes one or more metals, or alloys thereof, that are compatible (i.e., not harmful) with the skin. Similarly, in selected embodiments, the second chemical reactant may include water. In certain embodiments, the beneficial agent generated by the first and second chemical reactants includes an antioxidant such as hydrogen. | 2011-03-17 |
20110064824 | METHOD FOR ENRICHING WATER WITH OXYGEN BY AN ELECTROLYTIC PROCESS, OXYGEN ENRICHED WATER OR BEVERAGE AND USES THEREOF - The invention relates to a method for enriching water with oxygen by an electrolytic process, that comprises the following series of steps: the electrolysis of Cl | 2011-03-17 |
20110064825 | Method for preparing dispersions of precious metal nanoparticles and for isolating such nanoparticles from said dispersions - The present invention is directed to a method for preparing colloidal dispersions of precious metal nanoparticles selected from the group consisting of Pt, Au, Pd, Ag, Rh, Ru and mixtures or alloys thereof, and to a method for isolating such precious metal nanoparticles from these colloidal dispersions. The colloidal dispersions are prepared by reducing suitable precious metal precursor compounds in aqueous alkaline solutions at reaction temperatures between 40 and 70° C. and a pH≧12.0 in the presence of polysaccharides with average molecular weights (M | 2011-03-17 |
20110064826 | COMPOSITION FOR TREATING SKIN LESIONS - The present invention provides a composition for topical treatment of skin and mucosal membrane lesions comprising a synergistic combination of copper compound and | 2011-03-17 |
20110064827 | Active compound combinations - The present invention relates to compositions, in particular within a fungicide composition, which comprises (A) a dithiino-tetracarboximide of formula (I) and a further fungicidally active compound (B). Moreover, the invention relates to a method for curatively or preventively controlling the phytopathogenic fungi of plants or crops, to the use of a combination according to the invention for the treatment of seed, to a method for protecting a seed and to the treated seed. | 2011-03-17 |
20110064828 | TREATMENT OF METASTATIC TUMORS AND OTHER CONDITIONS - The present invention generally relates to pharmacology and, in particular, to the treatment of tumors and other conditions. In some aspects, the invention is directed to the treatment of subjects having tumors or cancers that are metastatic. Surprisingly, it has been found that certain compositions comprising oxidized glutathione-based compounds are able to effectively treat such cancers by inhibiting cell migration and/or invasion processes, and thus, inhibiting tumor cell metastases. Without being bound by any theory, it is believed that such compositions are effective since the compositions are able to suppress the activation of critical signaling pathways within cells that are used for cell migration, such as the ErbB2 and/or phosphoinositide-3 kinase (PI3K) pathways, including the downstream RhoA and AKT pathways. Such pathways are regulated by ERp5, which is a protein disulfide isomerase regulated using certain redox pathways, and those redox pathways are unusually sensitive to treatment using oxidized glutathione-based compounds. Thus, the composition of the instant invention, in some embodiments, are surprisingly effective at preventing tumor metastases. While other references have disclosed the treatment of cancers using oxidized glutathione-based compounds, no reference has suggested that signaling pathways used for cell migration, invasion and metastasis, such as the ErbB2, PI3K, RhoA, and AKT pathways, are highly susceptible to treatment by altering the redox state of the cell, e.g., by oxidized glutathione-based compounds. Accordingly, the use of such compositions to treat tumor metastases is surprising and could not be predicted given the teachings of the prior art. | 2011-03-17 |
20110064829 | PERSISTENT AND FAST ACTING ANTISEPTICS AND DISINFECTANTS BASED ON CALCIUM FLUORIDE - Antiseptic compounds that act as persistent and fast acting antiseptics and disinfectants. The base of these antiseptic actions is CaF | 2011-03-17 |
20110064830 | FILM-SHAPED PREPARATION COMPRISING OILY SUBSTANCES FOR ORAL ADMINISTRATION - Water-soluble, solid, film-shaped preparations comprising at least one film-forming polymer selected from the group consisting of the fully and partially hydrolyzed polyvinyl alcohols, and at least one water-insoluble, oily liquid which is incorporated into the film-forming polymer and amounts to at least 30 percent by weight, relative to the dry portion of the preparation. Methods for producing the preparations and the use thereof are also provided. | 2011-03-17 |
20110064831 | FUNGICIDAL COMPOSITIONS - The present invention relates to fungicidal compositions and particularly fungicidal compositions comprising anhydrous milk fat (AMF), soybean oil and/or coconut fat. The invention also relates to a fungicidal method employing a composition of the invention. The compositions and methods of the invention have applications in the management (prevention and control) of fungal growth in commercial and small scale crop production. | 2011-03-17 |
20110064832 | SKIN CARE FORMULATIONS - Disclosed are compositions and methods for treating skin comprising a chemically compatible combination of skin active ingredients comprising palmitoyl tetrapeptide-7, methylsilanol mannuronate, and | 2011-03-17 |
20110064833 | SYNERGISTIC HERBAL COMPOSITION AND PROCESS OF PREPARATION THEREOF - The present invention relates to a synergistic herbal composition for diabetes and related disorders comprising extracts of plant | 2011-03-17 |
20110064834 | NOVEL PEST REPELLANT COMPOSITION AND METHOD OF USE - The present disclosure relates generally to a novel pest repellant composition for use in repelling reptiles, rodents, birds, insects, and other unwanted pests. Advantageously, this pest repellant composition is safe, effective, economical to produce, and environmentally-friendly. It is used via spreading in an area of interest, for example. The novel pest repellant composition of the present invention generally includes between approximately 97-99% by weight of water, approximately 0.5-1.0% by weight of garlic juice or oil, approximately 0.5-1.0% by weight of neem oil, approximately 0.1 to 0.2% by weight of pepper wax or capsaicin, and approximately 0.1 to 0.2% by weight of a breaker (such as organo-polysiloxane, for example). | 2011-03-17 |
20110064835 | PROCESS FOR THE PREPARATION OF ACTIVE PRINCIPLES ON THERMAL WATER AND COMPOSITIONS COMPRISING THEM - The invention relates to a process for the preparation of a cosmetic or dermatological active principle, comprising the culturing of at least one nonphoto-synthetic and nonfruiting filamentous bacterium on a medium comprising at least one nonsulphurous mineral and/or thermal water. It also relates to a cosmetic or dermatological composition comprising at least one bacterium of the genus | 2011-03-17 |
20110064836 | DEVICE FOR PRODUCTION OF DRIP IRRIGATION TUBES - A device for producing a drip irrigation tube comprises an extrusion apparatus for extruding a tube body made of a thermoplastic synthetic material, a device for inserting metering elements in the extruded tube body and for pressing and connecting the metering elements in the tube body. Furthermore, a calibrating device for adjusting the extruded tube body to the desired outer shape is provided. Provided in addition are cooling devices, for cooling the extruded tube body with coolant, and a drilling device for making outlet holes in the vicinity of the metering elements for the water. The device for pressing and connecting the metering elements in the tube body is disposed in a pre-cooling chamber. Disposed after the pre-cooling chamber is a further chamber, in which the drilling device is disposed. Disposed following the further chamber is the main cooling chamber, the calibrating device being inserted between the further chamber and the main cooling chamber. Besides an exact placement of the outlet holes in the tube body, a savings in energy during carrying out of the drilling operation is also achievable by means of this configuration. | 2011-03-17 |
20110064837 | Non-Slip Activation Members - A mechanical activation system has a first activation member, a second activation member, an activation zone, and a non-slip zone. The first activation member has a first plurality of teeth, and the second activation member has a second plurality of teeth. The first plurality of teeth is capable of intermeshing with the second plurality of teeth. The activation zone includes a first portion of the first plurality of teeth and a first portion of the second plurality of teeth. The first portion of the first plurality of teeth and the first portion of the second plurality of teeth include teeth having continuous tips. The first non-slip zone includes a second portion of the first plurality of teeth or a second portion of the second plurality of teeth. The second portion includes a tooth having a discontinuous tip. | 2011-03-17 |
20110064838 | REPLICATION TOOLS AND RELATED FABRICATION METHOS AND APPARATUS - Durable replication tools are disclosed for replication of relief patterns in desired media, for example in optical recording or data storage media. Methods of making such durable replication tools are disclosed, including recording and developing a relief pattern on a selected surface of a support cylinder, creating a durable layer with a complementary relief replica of the pattern, separating the durable layer from the support cylinder. Apparatus are disclosed for fabricating such replication tools, including systems and apparatus for recording a desired relief pattern on a surface of a support cylinder. Also disclosed are electro deposition cells for forming a durable tool sleeve having a desired relief pattern. The replication tool relief features may have critical dimensions down to the micron and nanometer regime. | 2011-03-17 |
20110064839 | APPARATUS AND A METHOD FOR MAKING PLASTIC CONTAINERS BY BLOW-MOULDING PARISONS - An apparatus ( | 2011-03-17 |
20110064840 | MOULDING UNIT FOR A PLANT FOR BLOW-MOULDING PLASTIC CONTAINERS, PARTICULARLY BOTTLES - A moulding unit for a plant for blow-moulding plastic containers ( | 2011-03-17 |
20110064841 | Molding Apparatus for Modified Sulfur Concrete Substance Product - In the present invention, as a sulfur-containing material fully filled into a cavity of a mold body in which the inside of an outer mold having the cavity which can be hermetically sealed is heated to a temperature within a preset temperature range of which a lower limit is equal to or above a melting point of sulfur is cooled and contracted in the cavity, the sulfur-containing material stored in a filling tank in which a cover is attached to an upper end opening of filling tank, so that the inside of filling tank can be hermetically sealed, and also, the inside of filling tank is pressurized to a predetermined pressure, and the inside of filling tank is heated to a temperature within the preset temperature range, is replenished into the cavity by a pressure in filling tank to mold a modified sulfur concrete substance product. | 2011-03-17 |
20110064842 | COOLING DEVICE FOR MOLDING APPARATUS - A cooling device includes a housing and a die. The housing includes a top, a bottom, and a plurality of sidewalls interconnecting the bottom and the top. Two opposite sidewalls of the housing respectively defines a plurality of first inlets and outlets. The die is received in the housing and defines a plurality of first passages spanning opposite side surfaces, and the first passages are aligned with the first inlets and the outlets of the housing. A second passage is defined between the die and the sidewalls of the housing. The first and second passages are configured for conducting the cooling fluid to cool the die. | 2011-03-17 |
20110064843 | EJECTOR APPARATUS WITH ADDITIONAL EJECTOR FORCE - An ejector apparatus for an injection molding machine, comprising ejector pins mounted to a movable ejector plate and drivable by a drive device for ejecting injection molded parts from a cavity of an injection molding tool, wherein the ejector plate is displaceable by the drive device with a given normal ejector force acting on an injection molded part, wherein there is provided a reinforcing mechanism which when there is a jammed injection molded part reinforces the ejector force acting on the injection molded part to an increased additional ejector force for ejecting the jammed injection molded part above the given normal ejector force which can be or is made available by the drive device. | 2011-03-17 |
20110064844 | POULTRY DIET FOR IMPROVING TEXTURE - The present invention aims to provide a poultry diet that can soften the flesh quality of poultry meat and improve the texture, a method of producing a large amount of meat with improved texture by using the diet, and a breeding method of poultry having flesh quality with good texture, and a flesh quality softening agent for poultry to be used by addition to feed. | 2011-03-17 |
20110064845 | PROTEIN-RICH FEEDSTUFF WITH RESISTANCE TO LOWERED DIGESTIBILITY DUE TO HEAT DAMAGE - Protein-rich feedstuffs which contain at least one protein feed material and either betaine or at least one feed product which contains betaine are resistant to reduction of digestibility as a result of heat damage during drying. | 2011-03-17 |
20110064846 | METHODS FOR REDUCING REACTIVE CARBONYL SPECIES - Methods for reducing the concentration of reactive carbonyl species, for example, in thermally processed foods, including beverages, are provided herein. | 2011-03-17 |
20110064847 | METHOD OF DENATURING PROTEIN WITH ENZYMES - A method of denaturing a protein by treating the protein with a protein glutaminase and a transglutaminase, a food containing a protein having been denatured with these enzymes, and an enzyme preparation for denaturing a protein which contains these enzymes. A protein is denatured by adding protein glutaminase and transglutaminase to the protein substantially at the same timing, or adding protein glutaminase to the protein before the transglutaminase acts on the protein, or controlling the quantitative ratio of protein glutaminase to transglutaminase, by which a protein is treated, to a definite level. | 2011-03-17 |
20110064848 | USE OF ELECTRICITY TO INCREASE THE TRANSFER OF MOLECULES ACROSS BIOLOGICAL MEMBRANES FOR THE ACCELERATION OF DAIRY FERMENTATION - A process for preparing a dairy fermentation product comprises inoculating lactic acid bacteria into a dairy base composition and initiating fermentation. Electrodes are placed in direct contact to the inoculated dairy base composition, and electric pulses are created, whereby pores are formed in the lactic acid bacteria so that molecules in the dairy base composition gain entry into the lactic acid bacteria. | 2011-03-17 |
20110064849 | METHOD FOR PROCESSING COCOA BEANS - The invention relates to a method for processing cocoa beans wherein freshly harvested, unfermented, and preferably non-depulped, beans are pre-treated and are then immersed a first time within an aqueous acidic medium until the pH of said cocoa beans reaches a value of between 3.6 and 5.5 and incubated at a temperature of between 25 and 70° C. for less than 24 hours. Optionally the beans can then be immersed for a second time within an aqueous acidic medium or the first aqueous acidic medium can be alkalified until the pH of said cocoa beans reaches a value of between 4.5 and 6.5 and incubated at a temperature of between 25 and 70° C. for less than 24 hours. The obtained cocoa beans are then further dried. The invention also relates to cocoa beans that are obtained or obtainable by methods of the present invention, to the use thereof for preparing food products, preferably chocolate products, or cocoa products, including cocoa extracts, and to food products and cocoa products, including cocoa extracts thereby obtained. | 2011-03-17 |
20110064850 | METHOD OF PRODUCING FERMENTED TEA DRINK - Disclosed is a process for preparing a fermented tea drink comprising the steps of: adding water to fresh tea leaves and milling the mixture; removing a solid fraction from the mixture; and heating the liquid, or adding water to fresh tea leaves and milling the mixture; incubating the mixture with shaking for 1 to 40 minutes; removing a solid fraction from the mixture; and heating the liquid; to obtain the fermented tea drink. Catechins can be efficiently converted into theaflavin to provide a fermented tea drink that has a high content of theaflavin, theasinensins A and B, and gallic acid, that exhibits little bitterness and astringency, that is entirely free of cream down, and that has an excellent aroma and sweetness. | 2011-03-17 |
20110064851 | METHOD OF PRODUCING FERMENTED TEA DRINK RICH IN THEAFLAVINS - The present invention provides a convenient and economical process for preparing a fermented tea drink that exhibits little bitterness and astringency and that has an excellent aroma and sweetness. The fermented tea drink can be obtained by adding water to fresh tea leaves and milling for 1 second to 3 minutes with a mixer; incubating the mixture with standing for at least 15 minutes or with stirring semi-anaerobically; removing solid fraction from the mixture; and heating the liquid. The process of the present invention can efficiently convert catechins into theaflavin and can thereby provide a fermented tea drink with a high content of theaflavin, theasinensins A and B, and gallic acid. | 2011-03-17 |
20110064852 | PORTION CAPSULE AND USE OF A PORTION CAPSULE - Proposed is a portion capsule for producing a beverage, having a substantially frustoconical or cylindrical base element which has a cavity, and having a membrane which closes off the cavity, with a filter element being arranged within the cavity, which filter element divides the cavity into a first region for holding beverage raw material and a second region for holding a beverage extract, with the filter element being fastened to the base element by at least one fastening means which is arranged substantially in the region of a side, which is situated opposite the membrane, of the base element. | 2011-03-17 |
20110064853 | CARNALLITE-LIKE FOOD SALTS AND PRODUCTS THEREOF - Provided herein are salts for use in food products having the formula: MgCl | 2011-03-17 |
20110064854 | Process for Making a Healthy Snack Food - The present invention is directed towards a method for making a healthy snack food having an appearance and taste similar to conventional fried snack products without the use of an oil-frying process. The method of the present invention includes the steps of providing food slices from a starch-based food or dough. The food slices can be blanched and a controlled amount of oil can be added to enhance final organoleptical properties. The food slices are then rapidly dehydrated to a much lower moisture content in a primary drying step that simulates conventional frying dehydration rates. A food snack, such as a corn or potato-based snack, produced by this method is a low-fat, ready-to-eat snack having the conventional texture and taste associated with fried snack products. | 2011-03-17 |
20110064855 | CHECKERBOARD BAKING PAN SYSTEM AND METHOD - A checkerboard baking pan system includes at least one pan and an insert for seating inside the at least one pan. The pan has a substantially flat bottom wall and upstanding side walls surrounding the bottom wall to form a receptacle. The pan has a non-circular shape, with said non-circular shape having a length and a width. The insert has at least two longitudinally extending members and at least two cross-braces for coupling the longitudinally extending members together. A method for forming a non-circular checkerboard cake having multi-layers is also discussed and includes forming two or three layers having varying colors using the insert. | 2011-03-17 |
20110064856 | PROCESS TO OBTAIN A CRAB MEAT SUBSTITUTE FROM SHARK MEAT WHEREIN A PRODUCT IS OBTAINED HAVING QUALITY, TASTE, ODOR, COLOR AND APPEARANCE SIMILAR TO CRAB MEAT - A process for obtaining a crab meat substitute from shark— | 2011-03-17 |
20110064857 | Method for the Removal of Sediment from Sparkling Wines - Apparatus for the removal of sediment from sparkling wines, designed to remove the capsule covering the neck of a bottle ( | 2011-03-17 |
20110064858 | Apparatus for and product method of making a frozen confectionery - Apparatus for producing a serving of frozen confectionery product is characterized by a supply of liquid gas, a support for removably carrying a disposable container that holds a volume of unfrozen confectionery mix, and a holder for releasably holding a disposable agitator, such that the agitator extends into confectionery mix in the container. A valve controllably dispenses liquid gas into the confectionery mix in the container while relative motion is imparted to the container and agitator to agitate and admix the confectionery mix and liquid gas while the liquid gas mix evaporates to cool and freeze the confectionery mix, through a transfer of heat from the confectionery mix to the liquid gas and through the latent heat of evaporation of the liquid gas, to produce the frozen confectionery product. | 2011-03-17 |
20110064859 | FROZEN CONFECTION - A frozen confection having a pH of from 2.7 to 4.7 is provided. The frozen confection comprises at most 1.0 wt % milk protein, 0.1 to 5.0 wt % of calcium sulphate and 0.1 to 5.0 wt % of citric acid or malic acid or a mixture thereof. A process for manufacturing the frozen confection is also provided. | 2011-03-17 |
20110064860 | Dryblended Nutritional Powders - Disclosed are reconstitutable nutritional powders comprising carbohydrate, protein, and lipid wherein at least one carbohydrate, such as lactose, and powdered lecithin have been dryblended into the reconstitutable nutritional powders. Also disclosed are methods of manufacturing a reconstitutable nutritional powder including dryblending at least one carbohydrate and powdered lecithin into a base nutritional powder. The nutritional powders provide for reduced foaming upon reconstitution. | 2011-03-17 |
20110064861 | SALTY TASTE ENHANCER AND FOOD OR DRINK CONTAINING THE SAME - It is possible to provide an excellent salty taste enhancer that can compensate for insufficient salty taste when attempting to reduce the salt content of food. A salty taste enhancer obtained by adding a glutamic acid, containing dipeptide, specifically, Glu-Ala, Glu-Arg, Glu-Asn, Glu-Asp, Glu-Gln, Glu-Glu, Glu-Gly, Glu-His, Glu-Ile, Glu-Leu, Glu-Lys, Glu-Pro, Glu-Ser, Glu-Thr, Glu-Trp, Glu-Tyr, Glu-Val, Arg-Glu, Asn-Glu, Asp-Glu, Gln-Glu, His-Glu, Pro-Glu, Ser-Glu, Thr-Glu or Trp-Glu to an enzymatic decomposition product of a protein material and/or a basic amino acid, especially arginine. A method for producing these salty taste enhancers, a method for enhancing a salty taste by using these salty taste enhancers, and a food or drink that contains these salty taste enhancers. | 2011-03-17 |
20110064862 | Non-Dairy, Nut-Based Milk and Method of Production - A method for making non-dairy, nut-based milk is disclosed. The method includes mixing water and nut butter. A dry blend is added that includes one or more hydrocolloids selected from the group consisting of: gellan gum, guar gum, locust bean gum, and xanthan gum. The dry blend further includes one or more salts. The non-dairy, nut-based milk is substantially free of soy or soy-derived ingredients. | 2011-03-17 |
20110064863 | Mixture of Olive Oils - The mixture of olive oils comprises a first monovarietal extra-virgin olive oil and a second monovarietal extra-virgin olive oil mixed together and selected from the list comprising: Picual, Coratina, Cornicabra and Moraiolo. | 2011-03-17 |
20110064864 | Food Additive for Ruminants Based on Eugenol and Cinnamaldehyde - The invention concerns a composition based on a mixture of eugenol and cinnamaldehyde, as food additive for feeding ruminants. The composition may be incorporated in a food additive, or a salt block. The eugenol and the cinnamaldehyde may be natural or identical natural constituents. Administering the composition or the food additive increases meat production and milk production. | 2011-03-17 |
20110064865 | METHOD FOR PREPARING A BATCH OF ANIMAL FEED FROM A PLURALITY OF INGREDIENTS - A batch of animal feed from a plurality of ingredients is prepared in a mixer/feeder wagon ( | 2011-03-17 |
20110064866 | BLACK MULBERRY FLAVORED COMPOSITION AND METHOD OF PREPARATION - The present invention is a black mulberry flavored composition made up of water, tagette essence, blackberry juice concentrate, apple juice concentrate, blueberry essence, blueberry juice concentrate, grape essence, raspberry essence, ethyl alcohol and davana oil. There is also a method of manufacturing the black mulberry flavored composition through adding ingredients at various times and mixing those ingredients at various times during the method. | 2011-03-17 |
20110064867 | PROCESS FOR MANUFACTURING FLOWABLE POWDER DRUG COMPOSITIONS - Powder drug compositions exhibiting improved flow properties are manufactured by spraying a suspension of surface-modified nanoparticles having an average particle size diameter of less than 100 nm in a dryable liquid carrier onto particles of a powder ingredient of a drug composition. The liquid carrier is rapidly dried so as to leave the nanoparticles on the powder. Other ingredients of the powder drug composition can also be added. | 2011-03-17 |
20110064868 | LIQUID AND LOW MELTING COATINGS FOR STENTS - Stents with coatings comprising a combination of a restenosis inhibitor comprising an HMG-CoA reductase inhibitor and a carrier. Also provided are methods of coating stents with a combination of an HMG-CoA reductase inhibitor and a carrier. A preferred example of a restenosis inhibitor is cerivastatin. The stent coatings have been shown to release restenosis inhibitors in their active forms. | 2011-03-17 |
20110064869 | Coated Capillary Electrophoresis Tubes and System - The invention is directed to a capillary tube for electrophoresis that has a positively charged coating on the capillary inner surface that prevents positively charged analytes from adsorbing to the inner capillary surface. The capillary tube has an inner surface that is coated with a first polymer layer having a plurality of polymer groups comprising polyethylene imine, designated herein as (CH | 2011-03-17 |
20110064870 | PREPARING SUBSTRATES CONTAINING POLYMERS FOR METALLIZATION - Methods of swelling and topographically altering polymers of substrates using low foaming compositions are disclosed. Solvent swells which are stable, homogeneous and low foaming are applied to substrates containing polymers to swell and soften the polymers followed by applying an oxidizer to topographically alter and desmear the polymers in preparation for metallization of the substrate. | 2011-03-17 |
20110064871 | LAMINATED BODY FOR MANUFACTURING RESIN MOLD, LAMINATED BODY, RESIN MOLD AND METHOD FOR MANUFACTURING MAGNETIC RECORDING MEDIUM - A laminated body which forms a resin mold by compression molding using a master mold, the laminated body having: a pair of mutually facing base materials, a layer of a liquid or gel-like curable resin material sandwiched between the pair of base materials, and one or more flow suppression bodies, which are composed of a cured product of the curable resin material and are sandwiched between the pair of base materials, wherein the layer of the curable resin material is sealed by the pair of base materials and the flow suppression bodies. Also, a method for manufacturing a resin mold using the laminated body. | 2011-03-17 |
20110064872 | Materials for Travelled Surfaces - A mixture of material for providing at least a portion of a travelled surface. The mixture includes an aggregate with a plurality of particles. The mixture also includes a hydrocolloidal agent adapted to swell upon exposure to water to form a resilient and flexible binder, for substantially binding the particles of the aggregate together. The aggregate and the hydrocolloidal agent have an initial pH. The mixture also includes an agent for elevating the initial pH to a predetermined pH, and a hydrophilic agent. | 2011-03-17 |
20110064873 | METHOD FOR PRODUCING CARBON NANOCOILS - The present invention discloses a method for producing carbon nanocoils, which comprises: providing a metal substrate; depositing a tin precursor on the substrate; heating the substrate with the precursor to a predetermined temperature to form a catalyst on the substrate; placing the substrate in a quartz tube furnace; and introducing carbon source gas and protective gas into the quartz tube furnace to allow carbon nanocoils to grow on the surface of the catalyst. Another method for producing carbon nanocoils is also disclosed, which includes: depositing a mixed solution of iron acetate and tin acetate on a substrate; heating the substrate with the mixing solution to a predetermined temperature to form a catalyst on the substrate; placing the substrate in a quartz tube furnace; and introducing carbon source gas and protective gas into the quartz tube furnace to allow carbon nanocoils to grow on the surface of the catalyst. | 2011-03-17 |
20110064874 | Process For Coating Modified Bitumen Membranes Using Powder Coatings - A method of applying a powder coating composition during manufacture of modified bitumen roll roofing membranes, is provided. The coating composition is heat activated providing greater adherence to surfaces that it applied to, and greater reflective properties. The coating that has an initial energy efficiency rating greater than or equal to 0.65 for a low-sloped roof, or an initial energy efficiency greater than or equal to 0.25 for a steep-sloped roof. | 2011-03-17 |